The Joint Corp.
The Joint Corp. (JYNT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · JYNT · as of Jun 9, 2026
Key Statistics
Explore The Joint Corp. Data
jynt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 62.5%
The JYNT analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $20.00, representing +143.90% upside from the current price of $8.20.
Competitors & Peers
jynt competitorsJYNT
APYX
BTMD
CCLD
CGTX
DCGOStock Performance
Full HistoryAbout The Joint Corp.
The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main division…
what is the joint corp. · jynt stock overview · the joint corp. company profile · who is the joint corp. ceo · jynt NASDAQ · the joint corp. headquarters · the joint corp. business segments
About Stock Overview & Key Data
The Joint Corp. (JYNT) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Nov 11, 2014. As of the latest trading session, JYNT stock price is $8.20, with a market capitalization of $116.9M. The stock has returned -31.21% over the past 12 months and -5.96% year-to-date.
According to 8 Wall Street analysts, the consensus rating for The Joint Corp. stock is Buy, with an average 12-month price target of $20.00. In fiscal year 2025, The Joint Corp. reported revenue of $54.9M and net income of $2.9M. For detailed data — including The Joint Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, The Joint Corp. (JYNT) stock price is $8.20. The stock is traded on NASDAQ under the ticker symbol JYNT. The 52-week range is $7.50 – $13.00.